125 related articles for article (PubMed ID: 27472906)
1. Identification of Highly Potent Protein Kinase C-Related Kinase 1 Inhibitors by Virtual Screening, Binding Free Energy Rescoring, and in vitro Testing.
Slynko I; Schmidtkunz K; Rumpf T; Klaeger S; Heinzlmeir S; Najar A; Metzger E; Kuster B; Schüle R; Jung M; Sippl W
ChemMedChem; 2016 Sep; 11(18):2084-94. PubMed ID: 27472906
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening of PRK1 inhibitors: ensemble docking, rescoring using binding free energy calculation and QSAR model development.
Slynko I; Scharfe M; Rumpf T; Eib J; Metzger E; Schüle R; Jung M; Sippl W
J Chem Inf Model; 2014 Jan; 54(1):138-50. PubMed ID: 24377786
[TBL] [Abstract][Full Text] [Related]
3. Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1).
Ostrovskyi D; Rumpf T; Eib J; Lumbroso A; Slynko I; Klaeger S; Heinzlmeir S; Forster M; Gehringer M; Pfaffenrot E; Bauer SM; Schmidtkunz K; Wenzler S; Metzger E; Kuster B; Laufer S; Schüle R; Sippl W; Breit B; Jung M
Future Med Chem; 2016 Sep; 8(13):1537-51. PubMed ID: 27572962
[TBL] [Abstract][Full Text] [Related]
4. Multi-Target Chemometric Modelling, Fragment Analysis and Virtual Screening with ERK Inhibitors as Potential Anticancer Agents.
Halder AK; Giri AK; Cordeiro MNDS
Molecules; 2019 Oct; 24(21):. PubMed ID: 31671605
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new GSK-3β inhibitors through structure-based virtual screening.
Dou X; Jiang L; Wang Y; Jin H; Liu Z; Zhang L
Bioorg Med Chem Lett; 2018 Jan; 28(2):160-166. PubMed ID: 29208522
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening of B-Raf kinase inhibitors: A combination of pharmacophore modelling, molecular docking, 3D-QSAR model and binding free energy calculation studies.
Zhang W; Qiu KX; Yu F; Xie XG; Zhang SQ; Chen YJ; Xie HD
Comput Biol Chem; 2017 Oct; 70():186-190. PubMed ID: 28892749
[TBL] [Abstract][Full Text] [Related]
7. Identification of Pak1 inhibitors using water thermodynamic analysis.
Biswal J; Jayaprakash P; Suresh Kumar R; Venkatraman G; Poopandi S; Rangasamy R; Jeyaraman J
J Biomol Struct Dyn; 2020 Jan; 38(1):13-31. PubMed ID: 30661460
[TBL] [Abstract][Full Text] [Related]
8. Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.
Taha MO; Al-Sha'er MA; Khanfar MA; Al-Nadaf AH
Eur J Med Chem; 2014 Sep; 84():454-65. PubMed ID: 25050878
[TBL] [Abstract][Full Text] [Related]
9. Application of docking and QM/MM-GBSA rescoring to screen for novel Myt1 kinase inhibitors.
Wichapong K; Rohe A; Platzer C; Slynko I; Erdmann F; Schmidt M; Sippl W
J Chem Inf Model; 2014 Mar; 54(3):881-93. PubMed ID: 24490903
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1.
Najjar A; Platzer C; Luft A; Aßmann CA; Elghazawy NH; Erdmann F; Sippl W; Schmidt M
Eur J Med Chem; 2019 Jan; 161():479-492. PubMed ID: 30388464
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
13. Lestaurtinib inhibits histone phosphorylation and androgen-dependent gene expression in prostate cancer cells.
Köhler J; Erlenkamp G; Eberlin A; Rumpf T; Slynko I; Metzger E; Schüle R; Sippl W; Jung M
PLoS One; 2012; 7(4):e34973. PubMed ID: 22532837
[TBL] [Abstract][Full Text] [Related]
14. High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules.
Andrews PD; Becroft M; Aspegren A; Gilmour J; James MJ; McRae S; Kime R; Allcock RW; Abraham A; Jiang Z; Strehl R; Mountford JC; Milligan G; Houslay MD; Adams DR; Frearson JA
Biochem J; 2010 Nov; 432(1):21-33. PubMed ID: 20854259
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening.
Bajusz D; Ferenczy GG; Keserű GM
J Chem Inf Model; 2016 Jan; 56(1):234-47. PubMed ID: 26682735
[TBL] [Abstract][Full Text] [Related]
16. Discovery of CDK8/CycC Ligands with a New Virtual Screening Tool.
Chen W; Ren X; Chang CA
ChemMedChem; 2019 Jan; 14(1):107-118. PubMed ID: 30403831
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore and Docking Guided Virtual Screening Study for Discovery of Type I Inhibitors of VEGFR-2 Kinase.
Bhojwani HR; Joshi UJ
Curr Comput Aided Drug Des; 2017; 13(3):186-207. PubMed ID: 27981900
[TBL] [Abstract][Full Text] [Related]
18. A new protocol for predicting novel GSK-3β ATP competitive inhibitors.
Fang J; Huang D; Zhao W; Ge H; Luo HB; Xu J
J Chem Inf Model; 2011 Jun; 51(6):1431-8. PubMed ID: 21615159
[TBL] [Abstract][Full Text] [Related]
19. Structure-based modelling, scoring, screening, and in vitro kinase assay of anesthetic pkc inhibitors against a natural medicine library.
Shi BX; Chen FR; Sun X
SAR QSAR Environ Res; 2017 Feb; 28(2):151-163. PubMed ID: 28235389
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
